Skip to main content
Strolll logo

Strolll

Stafford, United KingdomSee on the mapFounded 2019

  • Neurorehabilitation and assistive tech
  • Series A

Strolll develops augmented reality technology for neurological rehabilitation, bringing visual cues, movement, and progression into patients’ real-world environments. Its platform is designed to make therapy more engaging and support clinicians in delivering high-intensity rehabilitation that fits clinical workflows.

Open roles
1
Raised
$47.2M
Mar 2025
Series A
Investors
12
Founded
2019

reccy insights

Recent highlights

Strolll’s most recent recorded financing activity was on Sep 3, 2026, when it announced a $1.35 million venture round led by IW Capital, alongside a $4.87 million debt financing and a $946,933 grant. Additional financing entries dated the same day include $4.15 million in conventional debt and a $7.34 million grant, although the available details do not clarify how these relate to the other September transactions. In 2025, the company raised a $13.40 million Series A dated Mar 11, 2025, with IW Capital listed as lead investor; Cleveland Clinic and Kluz Ventures also appear among the round’s investors. Earlier milestones include a $3 million corporate round on Aug 20, 2024, involving Cleveland Clinic and IW Capital, and a $2.56 million seed round dated Oct 17, 2023. Strolll’s Reality DTx product applies augmented reality to gait-and-balance rehabilitation for people with Parkinson’s disease and other neurological conditions.

Written by reccy's AI from company sites, press and funding records · updated Nov 2026

Open roles1

What makes Strolll distinct

  1. 01Projects visual gait cues into a patient’s real-world field of view using augmented-reality glasses.
  2. 02Combines cueing with gamified exercises and therapy progression for gait-and-balance rehabilitation.
  3. 03Supports clinicians in prescribing, tailoring, and remotely monitoring home-based programs.
  4. 04Focuses on Parkinson’s disease and other neurological conditions associated with fall risk.

Technology & products

  • Reality DTx

    An augmented-reality digital therapeutic for gait-and-balance neurorehabilitation. It delivers visual cues and gamified exercises through see-through AR glasses and supports clinician prescription, tailored programs, and remote monitoring.

  • Reality DTx, an augmented-reality digital therapeutic for neurorehabilitation.
  • See-through AR glasses that display cueing lines and exercises in the patient’s real environment.
  • Digital visual cueing integrated with movement exercises and therapy progression.
  • Clinician-oriented tools for program tailoring and remote monitoring.

Research roots1

Labs and research groups this company came from or works with.

  • Vrije Universiteit AmsterdamAmsterdam, Netherlands · No page yet
    Other link
Academic data: Carter Sciences

Funding

$47.2M disclosed
12 investors

Investors11

Also backed by
  • IW Capital
  • Kluz Ventures
  • Propel@YH
  • Midven

Similar companies

About Strolll

Products
Reality DTx
Leadership
Rupert BarksfieldTom FinnJorgen Ellis
Focus areas
Digital Health, augmented reality, neurorehabilitation, healthcare, physical therapy, clinical workflow, parkinsonism, B2B
Headquarters
Stafford, United Kingdom
Founded
2019
Employees
11–50
Status
Active · private